General Information of the Compound
| Compound ID |
CP0503654
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-Phenyl-3-(2-pyridin-3-yl-quinazolin-4-yl)-urea
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-[2-(3-Pyridyl)-4-quinazolinyl]-3-phenylurea
1-phenyl-3-(2-(pyridin-3-yl)quinazolin-4-yl)urea
BDBM50088462
CHEMBL305512
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H15N5O
|
||||||||||||||||||
| Molecular Weight |
341.374
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1ccccc1)Nc1nc(nc2ccccc12)-c1cccnc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H15N5O/c26-20(22-15-8-2-1-3-9-15)25-19-16-10-4-5-11-17(16)23-18(24-19)14-7-6-12-21-13-14/h1-13H,(H2,22,23,24,25,26)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GDOLLVJHBJTNPM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound